Cargando…
Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetine
BACKGROUND: Attention deficit/hyperactivity disorder (ADHD) often presents as an impairing lifelong condition in adults; yet it is currently underdiagnosed and undertreated in many European countries. This analysis examines the characteristics of adult patients with ADHD in a European (EUR) and non-...
Autores principales: | Upadhyaya, Himanshu, Adler, Lenard A, Casas, Miguel, Kutzelnigg, Alexandra, Williams, David, Tanaka, Yoko, Arsenault, Jody, Escobar, Rodrigo, Allen, Albert J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658949/ https://www.ncbi.nlm.nih.gov/pubmed/23648011 http://dx.doi.org/10.1186/1753-2000-7-14 |
Ejemplares similares
-
Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: An integrated analysis of the complete database of multicenter placebo-controlled trials
por: Asherson, Philip, et al.
Publicado: (2014) -
Validation of the adult attention-deficit/hyperactivity disorder quality-of-life scale in European patients: comparison with patients from the USA
por: Brod, Meryl, et al.
Publicado: (2015) -
Efficacy of atomoxetine in adult attention-Deficit/Hyperactivity Disorder: a drug-placebo response curve analysis
por: Faraone, Stephen V, et al.
Publicado: (2005) -
A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities
por: Clemow, David B, et al.
Publicado: (2017) -
Effect of Atomoxetine on Hyperactivity in an Animal Model of Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Moon, Su Jin, et al.
Publicado: (2014)